{"url":"https://lda.senate.gov/api/v1/filings/006e3dfd-355f-4e07-bae8-e068632bb2d1/","filing_uuid":"006e3dfd-355f-4e07-bae8-e068632bb2d1","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/006e3dfd-355f-4e07-bae8-e068632bb2d1/print/","filing_document_content_type":"text/html","income":null,"expenses":"4150000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Brad Tallamy","dt_posted":"2026-04-20T15:49:48-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"126 E Lincoln Avenue","registrant_address_2":"P.O. Box 2000","registrant_different_address":false,"registrant_city":"Rahway","registrant_state":"NJ","registrant_zip":"07065","registrant":{"id":24908,"url":"https://lda.senate.gov/api/v1/registrants/24908/","house_registrant_id":31304,"name":"MERCK & CO, INC.","description":null,"address_1":"126 E Lincoln Avenue","address_2":"P.O. Box 2000","address_3":null,"address_4":null,"city":"Rahway","state":"NJ","state_display":"New Jersey","zip":"07065","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BOB FILIPPONE","contact_telephone":"+1 202-508-4545","dt_updated":"2026-01-30T13:11:06.369278-05:00"},"client":{"id":132602,"url":"https://lda.senate.gov/api/v1/clients/132602/","client_id":12,"name":"MERCK & CO INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-13"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 1339, Pharmacy Benefit Manager Reform Act S. 2076, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2021 Issues relating to, 340B program integrity; 340B of the Public Health Services Act; 340B issues; 340B drug pricing program; Drug pricing; Drug pricing and reimbursement issues; Cost and value of medicines; Vaccine issues; Package inserts and e-labeling; Package inserts, labeling issues, and e-labeling authorization legislation; Pharmaceutical supply channel issues; Drug shortages issues; Inflation Reduction Act (P.L. 117-169), issues relating to drug pricing provisions; One Big Beautiful Bill Act (P.L. 119-21), issues related to health care; FY-2027 Budget and Appropriations Legislation; Budget reconciliation drug pricing provisions; Commerce Justice, Science, and related agencies appropriations legislation for 2026; Interior, Environment, and related agencies appropriations legislation for 2026; Intellectual property protection and trade issues; Animal Health Policy Issues; Animal Drug User Fee Act (ADUFA) & Funding for Electronic Animal Traceability; General pharmaceutical issues; Vaccine Injury Compensation Program (VICP); Vaccine Policy; Pharmacy Benefit Manager (PBM) policy issues; Pharmacy Benefit Manager reforms; Food and Drug Administration issues; Public Health Issues; Most Favored Nation (MFN) drug pricing; Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients; International competition in biopharmaceuticals.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67281,"prefix":null,"prefix_display":null,"first_name":"BRADLEY","nickname":null,"middle_name":"ALLEN","last_name":"ROSSIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69077,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"SCHWARTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":39434,"prefix":null,"prefix_display":null,"first_name":"ERIN","nickname":null,"middle_name":null,"last_name":"DARLING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":119825,"prefix":null,"prefix_display":null,"first_name":"BRADFORD","nickname":null,"middle_name":null,"last_name":"TALLAMY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149596,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"MCBATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153657,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"RADDER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues relating to, One Big Beautiful Bill Act (P.L. 119-21), issues related to health care; Medicare; Medicare Part B and D drug pricing issues; 340B program integrity; 340B of the Public Health Services Act; 340B drug pricing program; Drug pricing; Cost and value of medicines: Drug pricing and reimbursement issues; FY-2027 Budget and Appropriations Legislation; Medicaid drug rebate program (MDRP).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67281,"prefix":null,"prefix_display":null,"first_name":"BRADLEY","nickname":null,"middle_name":"ALLEN","last_name":"ROSSIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69077,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"SCHWARTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":39434,"prefix":null,"prefix_display":null,"first_name":"ERIN","nickname":null,"middle_name":null,"last_name":"DARLING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":119825,"prefix":null,"prefix_display":null,"first_name":"BRADFORD","nickname":null,"middle_name":null,"last_name":"TALLAMY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153657,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"RADDER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues relating to, Tax reform and tax policy, generally; Inflation Reduction Act (P.L. 117-169), provisions relating to budget reconciliation and taxes; Tax Cuts and Jobs Act (P.L. 115-97), provisions relating to tax reform.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67281,"prefix":null,"prefix_display":null,"first_name":"BRADLEY","nickname":null,"middle_name":"ALLEN","last_name":"ROSSIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69077,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"SCHWARTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"ANI","general_issue_code_display":"Animals","description":"Issues relating to, Animal Health Policy Issues; Animal Drug User Fee Act (ADUFA) & Funding for Electronic Animal Traceability; Agriculture, Rural Development , Food and Drug Administration, and Related Agencies Appropriations Bill, 2026; Commerce, Justice, Science, and Related Agencies Appropriations Bill, 2026; Interior, Environment, and Related Agencies Appropriations Bill 2026.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":149596,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"MCBATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67281,"prefix":null,"prefix_display":null,"first_name":"BRADLEY","nickname":null,"middle_name":"ALLEN","last_name":"ROSSIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}